Aurobindo Pharma Subsidiary Acquires 80% Stake in A1 Biochem Group

Aurobindo Pharma Limited's wholly owned subsidiary, Apitoria Pharma Private Limited, has approved the acquisition of an 80% ownership in the Contract Research Services business of A1 Biochem Group for USD 17 million. The acquisition includes A1 Biochem Labs (India) Private Limited and A1 Biochem Labs LLC, USA. A1 Biochem Group is a Contract Research Organization (CRO) providing chemistry services to pharmaceutical companies, biotechs, and academic institutions, primarily in the USA. The group reported a turnover of INR 1,024.42 Mn and EBITDA of INR 465.46 Mn in FY2025-26. This strategic move aims to bolster Aurobindo Pharma's capabilities in the pharmaceutical services sector.